Inositol Hexaphosphate As an Inhibitor and Potential Regulator of P47 Membrane Anchoring

Overview

Journal Biochemistry

Specialty Biochemistry

Date 2024 Apr 26

PMID 38669178

Authors

Angela M Develin

Brian Fuglestad

Affiliations

Soon will be listed here.

Abstract

As a key component for NADPH oxidase 2 (NOX2) activation, the peripheral membrane protein p47 translocates a cytosolic activating complex to the membrane through its PX domain. This study elucidates a potential regulatory mechanism of p47 recruitment and NOX2 activation by inositol hexaphosphate (IP6). Through NMR, fluorescence polarization, and FRET experimental results, IP6 is shown to be capable of breaking the lipid binding and membrane anchoring events of p47-PX with low micromolar potency. Other phosphorylated inositol species such as IP5(1,3,4,5,6), IP4(1,3,4,5), and IP3(1,3,4) show weaker binding and no ability to inhibit lipid interactions in physiological concentration ranges. The low micromolar potency of IP6 inhibition of the p47 membrane anchoring suggests that physiologically relevant concentrations of IP6 serve as regulators, as seen in other membrane anchoring domains. The PX domain of p47 is known to be promiscuous to a variety of phosphatidylinositol phosphate (PIP) lipids, and this regulation may help target the domain only to the membranes most highly enriched with the highest affinity PIPs, such as the phagosomal membrane, while preventing aberrant binding to other membranes with high and heterogeneous PIP content, such as the plasma membrane. This study provides insight into a potential novel regulatory mechanism behind NOX2 activation and reveals a role for small-molecule regulation in this important NOX2 activator.

References

Costello A, Glonek T, Myers T . 31P nuclear magnetic resonance-pH titrations of myo-inositol hexaphosphate. Carbohydr Res. 1976; 46(2):159-71. DOI: 10.1016/s0008-6215(00)84287-1. View

Lee W, Tonelli M, Markley J . NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics. 2014; 31(8):1325-7. PMC: 4393527. DOI: 10.1093/bioinformatics/btu830. View

Park J, Ma M, Ruedi J, Smith R, Babior B . The cytosolic components of the respiratory burst oxidase exist as a M(r) approximately 240,000 complex that acquires a membrane-binding site during activation of the oxidase in a cell-free system. J Biol Chem. 1992; 267(24):17327-32. View

Nalefski E, Slazas M, Falke J . Ca2+-signaling cycle of a membrane-docking C2 domain. Biochemistry. 1997; 36(40):12011-8. DOI: 10.1021/bi9717340. View

Jackson S, Al-Saigh S, Schultz C, Junop M . Inositol pentakisphosphate isomers bind PH domains with varying specificity and inhibit phosphoinositide interactions. BMC Struct Biol. 2011; 11:11. PMC: 3042905. DOI: 10.1186/1472-6807-11-11. View

Flannagan R, Jaumouille V, Grinstein S . The cell biology of phagocytosis. Annu Rev Pathol. 2011; 7:61-98. DOI: 10.1146/annurev-pathol-011811-132445. View

Paolo G, De Camilli P . Phosphoinositides in cell regulation and membrane dynamics. Nature. 2006; 443(7112):651-7. DOI: 10.1038/nature05185. View

Shears S . Assessing the omnipotence of inositol hexakisphosphate. Cell Signal. 2001; 13(3):151-8. DOI: 10.1016/s0898-6568(01)00129-2. View

Zilberter Y, Tabuena D, Zilberter M . NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders. Prog Neurobiol. 2023; 231:102539. PMC: 11758986. DOI: 10.1016/j.pneurobio.2023.102539. View

10.

Ago T, Kuribayashi F, Hiroaki H, Takeya R, Ito T, Kohda D . Phosphorylation of p47phox directs phox homology domain from SH3 domain toward phosphoinositides, leading to phagocyte NADPH oxidase activation. Proc Natl Acad Sci U S A. 2003; 100(8):4474-9. PMC: 153580. DOI: 10.1073/pnas.0735712100. View

11.

Lam G, Huang J, Brumell J . The many roles of NOX2 NADPH oxidase-derived ROS in immunity. Semin Immunopathol. 2010; 32(4):415-30. DOI: 10.1007/s00281-010-0221-0. View

12.

Babior B . NADPH oxidase: an update. Blood. 1999; 93(5):1464-76. View

13.

Komander D, Fairservice A, Deak M, Kular G, Prescott A, Downes C . Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates. EMBO J. 2004; 23(20):3918-28. PMC: 524332. DOI: 10.1038/sj.emboj.7600379. View

14.

Ueyama T, Tatsuno T, Kawasaki T, Tsujibe S, Shirai Y, Sumimoto H . A regulated adaptor function of p40phox: distinct p67phox membrane targeting by p40phox and by p47phox. Mol Biol Cell. 2006; 18(2):441-54. PMC: 1783789. DOI: 10.1091/mbc.e06-08-0731. View

15.

Violi F, Oliva A, Cangemi R, Ceccarelli G, Pignatelli P, Carnevale R . Nox2 activation in Covid-19. Redox Biol. 2020; 36:101655. PMC: 7381406. DOI: 10.1016/j.redox.2020.101655. View

16.

Gao H, Zhou H, Hong J . NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Pharmacol Sci. 2012; 33(6):295-303. PMC: 3477578. DOI: 10.1016/j.tips.2012.03.008. View

17.

Chandra M, Chin Y, Mas C, Feathers J, Paul B, Datta S . Classification of the human phox homology (PX) domains based on their phosphoinositide binding specificities. Nat Commun. 2019; 10(1):1528. PMC: 6449406. DOI: 10.1038/s41467-019-09355-y. View

18.

Irvine R, Schell M . Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol. 2001; 2(5):327-38. DOI: 10.1038/35073015. View

19.

Loffredo L, Ettorre E, Zicari A, Inghilleri M, Nocella C, Perri L . Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2. Oxid Med Cell Longev. 2020; 2020:8630275. PMC: 7016401. DOI: 10.1155/2020/8630275. View

20.

Drummond G, Sobey C . Endothelial NADPH oxidases: which NOX to target in vascular disease?. Trends Endocrinol Metab. 2014; 25(9):452-63. DOI: 10.1016/j.tem.2014.06.012. View